iMD Companies, Inc. (ICBU)
USD 0.0
(-4.44%)
USD 0.0
(-4.44%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -175.44 Thousand USD | 39.25% |
| 2022 | -288.8 Thousand USD | -123.15% |
| 2021 | -129.42 Thousand USD | -581.52% |
| 2020 | -18.99 Thousand USD | -19.96% |
| 2019 | -15.83 Thousand USD | 94.96% |
| 2018 | -313.95 Thousand USD | -122.02% |
| 2017 | 1.42 Million USD | 98.07% |
| 2016 | 719.73 Thousand USD | 344.79% |
| 2015 | -294.02 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -55.8 Thousand USD | 4.92% |
| 2024 Q1 | -58.69 Thousand USD | -9.74% |
| 2023 FY | -175.45 Thousand USD | 39.25% |
| 2023 Q3 | -27.18 Thousand USD | -12.5% |
| 2023 Q1 | -70.01 Thousand USD | -44.65% |
| 2023 Q2 | -24.16 Thousand USD | 65.49% |
| 2023 Q4 | -53.48 Thousand USD | -96.76% |
| 2022 Q2 | -94.79 Thousand USD | 23.17% |
| 2022 FY | -288.8 Thousand USD | -123.15% |
| 2022 Q3 | -22.24 Thousand USD | 76.54% |
| 2022 Q4 | -48.4 Thousand USD | -117.63% |
| 2022 Q1 | -123.37 Thousand USD | -698.51% |
| 2021 Q2 | -31.45 Thousand USD | -33.66% |
| 2021 Q4 | -15.45 Thousand USD | 73.81% |
| 2021 Q3 | -58.99 Thousand USD | -87.57% |
| 2021 FY | -129.42 Thousand USD | -581.52% |
| 2021 Q1 | -23.53 Thousand USD | 0.0% |
| 2020 FY | -18.99 Thousand USD | -19.96% |
| 2019 FY | -15.83 Thousand USD | 94.96% |
| 2018 FY | -313.95 Thousand USD | -122.02% |
| 2017 FY | 1.42 Million USD | 98.07% |
| 2016 FY | 719.73 Thousand USD | 344.79% |
| 2015 FY | -294.02 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | 85.874% |
| Arrayit Corporation | -3.62 Million USD | 95.157% |
| Atlantic International Corp. | -5.73 Million USD | 96.939% |
| Biocept, Inc. | -31.98 Million USD | 99.451% |
| Bioqual, Inc. | -19.63 Thousand USD | -793.401% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | 77.278% |
| DermTech, Inc. | -103.73 Million USD | 99.831% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.007% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 99.158% |
| IDenta Corp. | -1499.00 USD | -11604.203% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 106.257% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 553.466% |
| InVitro International | -25.33 Thousand USD | -592.395% |
| Lumos Diagnostics Holdings Limited | -7.12 Million USD | 97.537% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -201.91% |
| Medical Imaging Corp. | -819.48 Thousand USD | 78.591% |
| NovelStem International Corp. | -3.52 Million USD | 95.024% |
| Optigenex Inc. | 1.39 Million USD | 112.614% |
| PharmChem, Inc. | 973.14 Thousand USD | 118.029% |
| Proteome Sciences plc | -1.62 Million USD | 89.177% |
| Response Genetics, Inc | -21.37 Million USD | 99.179% |
| Rennova Health, Inc. | -1.4 Million USD | 87.553% |
| RushNet, Inc. | -684.7 Thousand USD | 74.376% |
| ScreenPro Security Inc. | -2.59 Million USD | 93.232% |
| Stella Diagnostics Inc. | -11.42 Million USD | 98.465% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 97.735% |
| Todos Medical Ltd. | -9.74 Million USD | 98.2% |